Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Other Non-Current Assets of $80.7 million for Q2 2026, up 46.99% on a QoQ basis from $54.9 million in Q1 2026, and up 79.87% year-over-year from $44.8 million in Q2 2025.
Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Other Non-Current Assets for 10 years, with the latest figure at $80.7 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 79.87% year-over-year to $80.7 million in Q2 2026; TTM through Jun 2026 was $80.7 million, a 79.87% increase from a year earlier, with the FY2025 full-year figure at $57.8 million, down 3.87% from the prior year.
- Other Non-Current Assets was $80.7 million for Q2 2026 at Amneal Pharmaceuticals, up from $54.9 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $108.3 million in Q3 2022, with the low at $36.3 million in Q3 2024.
- Average Other Non-Current Assets over 5 years is $69.4 million, with a median of $68.8 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 454.39% in 2022, then tumbled 59.26% in 2024.
- Over 5 years, Other Non-Current Assets stood at $103.2 million in 2022, then slumped by 46.21% to $55.5 million in 2023, then grew by 8.31% to $60.1 million in 2024, then decreased by 3.87% to $57.8 million in 2025, then jumped by 39.55% to $80.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $80.7 million (Q2 2026), $54.9 million (Q1 2026), and $57.8 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 1.79 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 1.06 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 11.74 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 80.67 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 358.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 11.62 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 14.42 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 33.39 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 666,000.00 |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.67 Mn |
| Mar 31, 2026 | 54.88 Mn |
| Dec 31, 2025 | 57.81 Mn |
| Sep 30, 2025 | 39.46 Mn |
| Jun 30, 2025 | 44.85 Mn |
| Mar 31, 2025 | 45.42 Mn |
| Dec 31, 2024 | 60.13 Mn |
| Sep 30, 2024 | 36.27 Mn |
| Jun 30, 2024 | 77.03 Mn |
| Mar 31, 2024 | 73.75 Mn |
| Dec 31, 2023 | 55.52 Mn |
| Sep 30, 2023 | 89.04 Mn |
| Jun 30, 2023 | 93.24 Mn |
| Mar 31, 2023 | 86.43 Mn |
| Dec 31, 2022 | 103.22 Mn |
| Sep 30, 2022 | 108.26 Mn |
| Jun 30, 2022 | 79.84 Mn |
| Mar 31, 2022 | 63.94 Mn |
| Dec 31, 2021 | 20.61 Mn |
| Sep 30, 2021 | 19.53 Mn |
Amneal Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();